Avista Therapeutics, a preclinical gene therapy company built on deep clinical, computational and gene therapy expertise, today announced the significant expansion of its gene therapy platform.

Whole-genome sequencing detects single nucleotide variants but tends to miss larger changes, such as deletions, insertions, duplications, and inversions. Using a new machine-learning method to analyze ...

A new study published in the journal Addiction Neuroscience provides evidence that cannabidiol may help prevent the ...

Structural variations (SVs), including insertions, deletions, inversions, and substitutions, can profoundly influence gene ...